# Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

> **NCT07405736** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 124 (estimated)

## Conditions studied

- Colorectal Cancer Metastatic
- Peritoneal (Metastatic) Cancer
- Peritoneal Metastasis
- Colorectal Cancer (CRC)
- MSS Metastatic Colorectal Cancer

## Interventions

- **DRUG:** maintenance therapy plus lubiprostone
- **DRUG:** maintenance therapy

## Key facts

- **NCT ID:** NCT07405736
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07405736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07405736, "Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07405736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*